Anna Weiss

3.6k total citations · 1 hit paper
120 papers, 1.8k citations indexed

About

Anna Weiss is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Anna Weiss has authored 120 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Cancer Research, 61 papers in Oncology and 40 papers in Pathology and Forensic Medicine. Recurrent topics in Anna Weiss's work include Breast Cancer Treatment Studies (70 papers), Breast Lesions and Carcinomas (35 papers) and HER2/EGFR in Cancer Research (23 papers). Anna Weiss is often cited by papers focused on Breast Cancer Treatment Studies (70 papers), Breast Lesions and Carcinomas (35 papers) and HER2/EGFR in Cancer Research (23 papers). Anna Weiss collaborates with scholars based in United States, Canada and Italy. Anna Weiss's co-authors include Elizabeth A. Mittendorf, Tari A. King, Sarah L. Blair, David C. Chang, Katherine C. Lee, Kelly K. Hunt, Moshe Tal, Shu Chien, Phu Hung Nguyen and Yi-Shuan Li and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Circulation Research.

In The Last Decade

Anna Weiss

105 papers receiving 1.8k citations

Hit Papers

Prognostic and Biologic Significance of ERBB2-Low Express... 2022 2026 2023 2024 2022 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast Cancer
    2022 147 citations Paolo Tarantino, Qingchun Jin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Weiss United States 24 971 689 492 364 354 120 1.8k
Anne Eaton United States 29 931 1.0× 899 1.3× 781 1.6× 555 1.5× 147 0.4× 92 2.2k
Lily Lai United States 25 453 0.5× 924 1.3× 530 1.1× 271 0.7× 361 1.0× 75 1.9k
Floor Backes United States 32 523 0.5× 895 1.3× 648 1.3× 640 1.8× 522 1.5× 179 3.4k
Lisa M. Landrum United States 24 348 0.4× 829 1.2× 710 1.4× 348 1.0× 520 1.5× 87 2.9k
Lucìa Mangone Italy 22 373 0.4× 1.3k 1.8× 289 0.6× 318 0.9× 345 1.0× 96 2.1k
Som D. Mukherjee Canada 25 414 0.4× 968 1.4× 415 0.8× 137 0.4× 560 1.6× 85 2.0k
Anne Floquet France 30 521 0.5× 1.3k 1.9× 665 1.4× 572 1.6× 442 1.2× 170 3.3k
P.A. Lawton United Kingdom 12 817 0.8× 562 0.8× 313 0.6× 321 0.9× 105 0.3× 19 1.4k
Vani Parmar India 20 782 0.8× 847 1.2× 247 0.5× 239 0.7× 112 0.3× 106 1.5k
Sharon S. Lum United States 22 364 0.4× 637 0.9× 392 0.8× 276 0.8× 95 0.3× 102 1.4k

Countries citing papers authored by Anna Weiss

Since Specialization
Citations

This map shows the geographic impact of Anna Weiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Weiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Weiss more than expected).

Fields of papers citing papers by Anna Weiss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Weiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Weiss. The network helps show where Anna Weiss may publish in the future.

Co-authorship network of co-authors of Anna Weiss

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Weiss. A scholar is included among the top collaborators of Anna Weiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Weiss. Anna Weiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Weiss, Anna, Qingchun Jin, Nabihah Tayob, et al.. (2025). Axillary Management and Outcomes After Neoadjuvant Endocrine Therapy in the Randomized PELOPS Trial. Annals of Surgical Oncology. 33(3). 2275–2283.
5.
Gooch, Jessica C., et al.. (2025). Same Day Discharges Among Elderly Mastectomy Patients: A Single Institution Prospective Study. Annals of Surgical Oncology. 32(8). 5521–5527.
6.
Weiss, Anna, et al.. (2023). A Systematic Review of Breast Implant-Associated Squamous Cell Carcinoma. Cancers. 15(18). 4516–4516. 8 indexed citations
7.
Rojas, Kristin E., et al.. (2023). Endocrine Therapy for Surgeons: Practical Pearls for Managing Menopausal, Bone Loss and Sexual Adverse Effects. Annals of Surgical Oncology. 30(10). 5951–5961. 3 indexed citations
8.
Weiss, Anna, Olga Martínez‐Sáez, Adrienne G. Waks, et al.. (2023). Nodal positivity and systemic therapy among patients with clinical T1–T2N0 human epidermal growth factor receptor‐positive breast cancer: Results from two international cohorts. Cancer. 129(12). 1836–1845. 8 indexed citations
9.
Weiss, Anna, et al.. (2022). Rates of pathologic nodal disease among cN0 and cN1 patients undergoing routine axillary ultrasound and neoadjuvant chemotherapy. Breast Cancer Research and Treatment. 195(2). 181–189. 9 indexed citations
10.
Escandón, Joseph M., Anna Weiss, Rahim Nazerali, et al.. (2022). Breast reconstruction using the Latissimus Dorsi Flap and Immediate Fat Transfer (LIFT): A systematic review and meta-analysis. Journal of Plastic Reconstructive & Aesthetic Surgery. 75(11). 4106–4116. 23 indexed citations
11.
Tarantino, Paolo, Qingchun Jin, Rinath Jeselsohn, et al.. (2022). 1MO Prognostic and biologic significance of HER2-low expression in early breast cancer. Annals of Oncology. 33. S124–S124. 5 indexed citations
12.
O’Sullivan, Ciara C., Karla V. Ballman, Linda McCall, et al.. (2021). Alliance A011801 (compassHER2 RD): Postneoadjuvant T-DM1 + Tucatinib/Placebo in Patients with Residual HER2-Positive Invasive Breast Cancer. Future Oncology. 17(34). 4665–4676. 19 indexed citations
13.
Cynthia, X., Vera J. Suman, A. Marilyn Leitch, et al.. (2020). ALTERNATE: Neoadjuvant endocrine treatment (NET) approaches for clinical stage II or III estrogen receptor-positive HER2-negative breast cancer (ER+ HER2- BC) in postmenopausal (PM) women: Alliance A011106.. Journal of Clinical Oncology. 38(15_suppl). 504–504. 27 indexed citations
14.
Minami, Christina A., Olga Kantor, Anna Weiss, et al.. (2020). Association Between Time to Operation and Pathologic Stage in Ductal Carcinoma in Situ and Early-Stage Hormone Receptor-Positive Breast Cancer. Journal of the American College of Surgeons. 231(4). 434–447e2. 21 indexed citations
15.
Kantor, Olga, Stephanie M. Wong, Anna Weiss, et al.. (2020). Prognostic significance of residual nodal disease after neoadjuvant endocrine therapy for hormone receptor-positive breast cancer. npj Breast Cancer. 6(1). 35–35. 28 indexed citations
16.
Weiss, Anna, Heather Lin, Gildy V. Babiera, et al.. (2019). Evolution in practice patterns of axillary management following mastectomy in patients with 1–2 positive sentinel nodes. Breast Cancer Research and Treatment. 176(2). 435–444. 21 indexed citations
17.
Weiss, Anna, Ralitza Parina, Viridiana J. Tapia, et al.. (2018). Assessing the domino effect: Female physician industry payments fall short, parallel gender inequalities in medicine. The American Journal of Surgery. 216(4). 723–729. 22 indexed citations
18.
Weiss, Anna, Heather Lin, Yu Shen, et al.. (2018). Factors associated with improved outcomes for metastatic inflammatory breast cancer patients. Breast Cancer Research and Treatment. 169(3). 615–623. 14 indexed citations
19.
Weiss, Anna, Elizabeth A. Mittendorf, Sarah M. DeSnyder, et al.. (2017). Expanding Implementation of ACOSOG Z0011 in Surgeon Practice. Clinical Breast Cancer. 18(4). 276–281. 25 indexed citations
20.
Weinberger, Ed, et al.. (1975). [Lymphedema of the upper limb as the presenting symptom of breast carcinoma].. PubMed. 88(4). 161–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Eaton Breakdown of academic impact, for papers by Lily Lai Breakdown of academic impact, for papers by Floor Backes Breakdown of academic impact, for papers by Lisa M. Landrum Breakdown of academic impact, for papers by Lucìa Mangone Breakdown of academic impact, for papers by Som D. Mukherjee Breakdown of academic impact, for papers by Anne Floquet Breakdown of academic impact, for papers by P.A. Lawton Breakdown of academic impact, for papers by Vani Parmar Breakdown of academic impact, for papers by Sharon S. Lum
Rankless by CCL
2026